Carrasco, C.; Tittarelli, A.; Paillaleve, N.; Pozo, M.D.; Rojas-SepĂşlveda, D.; BarrĂa, O.; Fluxá, P.; Hott, M.; Martin, C.; Quezada, C.;
et al. The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder-Cancer Patients. Diagnostics 2021, 11, 153.
https://doi.org/10.3390/diagnostics11020153
AMA Style
Carrasco C, Tittarelli A, Paillaleve N, Pozo MD, Rojas-SepĂşlveda D, BarrĂa O, Fluxá P, Hott M, Martin C, Quezada C,
et al. The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder-Cancer Patients. Diagnostics. 2021; 11(2):153.
https://doi.org/10.3390/diagnostics11020153
Chicago/Turabian Style
Carrasco, Cristian, AndrĂ©s Tittarelli, Natalia Paillaleve, Maeva Del Pozo, Daniel Rojas-SepĂşlveda, Omar BarrĂa, Paula Fluxá, Melissa Hott, Carolina Martin, Claudia Quezada,
and et al. 2021. "The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder-Cancer Patients" Diagnostics 11, no. 2: 153.
https://doi.org/10.3390/diagnostics11020153
APA Style
Carrasco, C., Tittarelli, A., Paillaleve, N., Pozo, M. D., Rojas-SepĂşlveda, D., BarrĂa, O., Fluxá, P., Hott, M., Martin, C., Quezada, C., & Salazar-Onfray, F.
(2021). The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder-Cancer Patients. Diagnostics, 11(2), 153.
https://doi.org/10.3390/diagnostics11020153